1. Ayechu-Muruzabal V, van Stigt AH, Mank M, Willemsen LEM, Stahl B, Garssen J, et al. Diversity of Human Milk Oligosaccharides and Effects on Earl Life Immune Development. Front Pediatr. 2018;6:239
  2. Jantscher-Krenn E, Bode L. Human milk oligosaccharides and their potential benefits for the breast-fed neonate. Minerva Pediatr. 2012;64(1):83-99
  3. HMO 3’-GL豐富存在於初乳中,He Y, Liu S, Leone S, Newburg DS. Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol. 2014;7(6):1326-39.
  4. Varasteh S, Van't Land B, Giziakis I, Mank M, Stahl B, Wiertsema S, et al. Human milk oligosaccharide 3'-galactosyllactose can protect the intestinal barrier to challenges. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(S1):N-P-016.
  5. Alfonso Rodriguez-Herrera, et al., Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial. Nutrients. 2019;11(7):1530. doi: 10.3390/nu11071530.
  6. 數據來源:根據IRI International 截至2019年4月以及尼爾森截至2019年7月之52周嬰幼兒奶粉零售研究數據
  7. 僅包含達能產品及其業務地區
  8. *母乳寡醣HMO 3’-GL來自我們獨特的製程